Huihao Xu

402 total citations
15 papers, 293 citations indexed

About

Huihao Xu is a scholar working on Cancer Research, Molecular Biology and Immunology. According to data from OpenAlex, Huihao Xu has authored 15 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Huihao Xu's work include MicroRNA in disease regulation (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Reproductive System and Pregnancy (2 papers). Huihao Xu is often cited by papers focused on MicroRNA in disease regulation (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Reproductive System and Pregnancy (2 papers). Huihao Xu collaborates with scholars based in China, United States and Canada. Huihao Xu's co-authors include Degui Lin, Yipeng Jin, Kai Fan, Jiafeng Gao, Jiahao Lin, Haodi Dong, Ying Zhao, Zhongjie Liu, Shuaiyu Wang and Tariq Hussain and has published in prestigious journals such as International Journal of Pharmaceutics, Frontiers in Pharmacology and European Journal of Pharmaceutical Sciences.

In The Last Decade

Huihao Xu

10 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huihao Xu China 7 105 83 48 46 36 15 293
Kai Fan China 13 149 1.4× 80 1.0× 15 0.3× 39 0.8× 14 0.4× 35 453
Mahboubeh Ebrahimian Iran 11 192 1.8× 96 1.2× 31 0.6× 60 1.3× 22 0.6× 19 333
Nidhi Puranik India 12 219 2.1× 50 0.6× 24 0.5× 86 1.9× 49 1.4× 42 520
Pei Gao China 11 167 1.6× 65 0.8× 80 1.7× 28 0.6× 41 1.1× 24 394
Cătălin Ţucureanu Romania 14 133 1.3× 41 0.5× 40 0.8× 80 1.7× 60 1.7× 32 497
※※※※ Suzuki Japan 9 175 1.7× 67 0.8× 22 0.5× 52 1.1× 21 0.6× 23 442
Degui Lin China 13 239 2.3× 85 1.0× 100 2.1× 50 1.1× 101 2.8× 25 538
Mahere Rezazade Bazaz Iran 9 143 1.4× 55 0.7× 59 1.2× 58 1.3× 25 0.7× 12 360
Hanitrarimalala Veroniaina China 12 150 1.4× 112 1.3× 21 0.4× 109 2.4× 20 0.6× 12 368
Mingna Li China 12 157 1.5× 53 0.6× 111 2.3× 36 0.8× 27 0.8× 50 374

Countries citing papers authored by Huihao Xu

Since Specialization
Citations

This map shows the geographic impact of Huihao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huihao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huihao Xu more than expected).

Fields of papers citing papers by Huihao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huihao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huihao Xu. The network helps show where Huihao Xu may publish in the future.

Co-authorship network of co-authors of Huihao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Huihao Xu. A scholar is included among the top collaborators of Huihao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huihao Xu. Huihao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Xu, Huihao, et al.. (2025). A Conceptual Review of Gut, Skin, and Oral Microbiota in Autoimmune Bullous Diseases: From Dysbiosis to Therapeutic Potential. Journal of Inflammation Research. Volume 18. 13925–13943.
2.
3.
Xu, Huihao, et al.. (2025). The impact of digital economy on regional green and high-quality economic development in China. Technological and Economic Development of Economy. 31(4). 1093–1129.
4.
Xu, Huihao, et al.. (2025). Ferroptosis of Immune Cells in Infection, Inflammation and Tumor Progression. Biomolecules. 15(10). 1464–1464.
5.
6.
7.
Gao, Jiafeng, Yi-Nan Zhang, Jingwen Cui, et al.. (2021). A Polysaccharide From the Whole Plant of Plantago asiatica L. Enhances the Antitumor Activity of Dendritic Cell-Based Immunotherapy Against Breast Cancer. Frontiers in Pharmacology. 12. 678865–678865. 22 indexed citations
8.
Yang, Heng, Lin Fu, Jiayu Wen, et al.. (2021). Identification and validation of key miRNAs and miRNA–mRNA regulatory network associated with uterine involution in postpartum Kazakh sheep. Archives animal breeding/Archiv für Tierzucht. 64(1). 119–129. 2 indexed citations
9.
Yang, Heng, Lin Fu, Jiayu Wen, et al.. (2021). Comparative analysis of differentially expressed miRNAs related to uterine involution in the ovine ovary and uterus. Archives animal breeding/Archiv für Tierzucht. 64(1). 167–175. 4 indexed citations
10.
Cui, Jingwen, Yipeng Jin, Huihao Xu, et al.. (2021). Research Progress on the Mechanism of the Acupuncture Regulating Neuro-Endocrine-Immune Network System. Veterinary Sciences. 8(8). 149–149. 34 indexed citations
11.
12.
Cheng, Nan, Ying Zhao, Huihao Xu, et al.. (2019). Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling. BMC Veterinary Research. 15(1). 276–276. 31 indexed citations
13.
Gao, Jiafeng, Kai Fan, Yipeng Jin, et al.. (2019). PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden. European Journal of Pharmaceutical Sciences. 140. 105070–105070. 49 indexed citations
14.
15.
Lin, Jiahao, Qiang Cai, Yanjun Xu, et al.. (2017). PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect. International Journal of Pharmaceutics. 536(1). 272–282. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Fan Breakdown of academic impact, for papers by Mahboubeh Ebrahimian Breakdown of academic impact, for papers by Nidhi Puranik Breakdown of academic impact, for papers by Pei Gao Breakdown of academic impact, for papers by Cătălin Ţucureanu Breakdown of academic impact, for papers by ※※※※ Suzuki Breakdown of academic impact, for papers by Degui Lin Breakdown of academic impact, for papers by Mahere Rezazade Bazaz Breakdown of academic impact, for papers by Hanitrarimalala Veroniaina Breakdown of academic impact, for papers by Mingna Li
Rankless by CCL
2026